Evidence map›Paper›PMID 41580803›Full record

ArticlePediatric rheumatology online journal2026

TeMPRA: advancing continuing professional development in pediatric rheumatology in Japan.

Hiroyuki Wakiguchi, Kunio Hashimoto, Masato Yashiro, Kenichi Nishimura, Takasuke Ebato, Keiji Akamine, Yoji Uejima, Tomomi Sato, Yuichi Yamasaki, Junko Yasumura and 14 more

Abstract read
In one paragraph

Article in Pediatric rheumatology online journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Hiroyuki WakiguchiDivision of General Pediatrics and Emergency Medicine, Department of Pediatrics, Oita University Faculty of Medicine, 1-1 Idaigaoka Hasama-machi, Yufu, Oita, 879-5593, Japan. hiroyuki@yamaguchi-u.ac.jp.
Kunio HashimotoDepartment of Pediatrics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8523, Japan.
Masato YashiroDepartment of Pediatrics, Okayama University Hospital, Okayama, 700-8558, Japan.
Kenichi NishimuraDepartment of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, 236-0004, Japan.
Takasuke EbatoDepartment of Pediatrics, Kitasato University, Sagamihara, 252-0374, Japan.
Keiji AkamineDepartment of Nephrology and Rheumatology, Tokyo Metropolitan Children's Medical Center, Fuchu, 183-8561, Japan.
Yoji UejimaDivision of Infectious Diseases and Immunology, Saitama Children's Medical Center, Saitama, 330-8777, Japan.
Tomomi SatoClinical Education Center for Physicians, Shiga University of Medical Science, Shiga, 520-2192, Japan.
Yuichi YamasakiDepartment of Pediatrics, Kagoshima University Hospital, Kagoshima, 890-8520, Japan.
Junko YasumuraDepartment of Pediatrics, Hiroshima Prefectural Hospital Organization Futabanosato Prefectural Hospital, Hiroshima, 732-0057, Japan.
Fumiko OkazakiDepartment of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, 755-8505, Japan.
Toshitaka KizawaDepartment of Pediatrics, Japan Community Health Care Organization Sapporo Hokushin Hospital, Sapporo, 004-8618, Japan.
Ryuhei YasuokaDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Tomoaki IshikawaDepartment of Pediatrics, Nara Medical University, Kashihara, 634-8522, Japan.
Takeshi YamamotoDepartment of Pediatrics, Chiba University Graduate School of Medicine, Chiba, 260-8670, Japan.
Yuji FujitaDepartment of Pediatrics, Dokkyo Medical University, Shimotsuga, 321-0293, Japan.
Naohiro ItohDepartment of Pediatrics, Faculty of Medical Sciences, University of Fukui, Fukui, 910-1193, Japan.
Asami TakasakiDepartment of Pediatrics, School of Medicine, University of Toyama, Toyama, 930-0194, Japan.
Nodoka SakuraiDepartment of Pediatrics, NTT East Medical Center Sapporo, Sapporo, 060-0061, Japan.
Kazuo SuzukiSuzuki Kids Clinic, Hiratsuka, 254-0002, Japan.
Tasuku TamaiDivision of General Pediatrics and Emergency Medicine, Department of Pediatrics, Oita University Faculty of Medicine, 1-1 Idaigaoka Hasama-machi, Yufu, Oita, 879-5593, Japan.
Naoki HiranoDepartment of Public Health and Epidemiology, Faculty of Medicine, Oita University, Yufu, 879-5593, Japan.
Nami OkamotoDepartment of Pediatrics, Osaka Rosai Hospital, Japan Organization of Occupational Health and Safety, Sakai, 591-8025, Japan.
Masaki ShimizuDepartment of Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8519, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the context of the global shortage of pediatric rheumatologists, mid-career specialists who can play key roles in regional education, research, and clinical practice have become increasingly important. In Japan, the Team of Mid-career Pediatric Rheumatologists Alliance (TeMPRA) was founded in 2014 to support continuing professional development (CPD) and foster collaboration among mid-career pediatric rheumatologists. The aim of this study was to characterize the current status and future perspectives of the TeMPRA members.

methodsIn 2024, a cross-sectional, web-based survey was conducted among all 37 active members of the TeMPRA across Japan. Data were collected on career trajectories, educational roles, research activities, clinical practices, and international engagement. Categorical variables were compared using appropriate statistical tests, with a significance level of 0.05.

resultsResponses were obtained from 35 members (response rate: 95%). Most respondents (71%) were affiliated with university hospitals, and 60% had > 10 years of experience in pediatric rheumatology. Compared with those working in community hospitals, respondents affiliated with university hospitals were significantly more likely to be involved in research activities (50% vs. 0%, P = 0.0261) and global professional contributions (88% vs. 0%, P < 0.0001). Overall, 54% of respondents were engaged in teaching students or early-career pediatric rheumatologists, while 43% were involved in clinical or basic research, most commonly focusing on juvenile idiopathic arthritis and systemic lupus erythematosus. Collectively, respondents were responsible for the care of 1,677 children with pediatric rheumatic diseases. While all respondents reported willingness to contribute to pediatric rheumatology at the regional level, 94% and 71% reported willingness to contribute at the national and global levels, respectively.

conclusionsThis nationwide survey highlights the substantial educational roles, research activities, and clinical practices of mid-career pediatric rheumatologists in Japan and suggests that the TeMPRA framework can serve as a valuable model for supporting CPD and workforce sustainability. Similar alliance-based approaches may be applicable in other countries facing comparable challenges in pediatric rheumatology.

Indexed as

Education, Medical, ContinuingPediatricsRheumatologistsRheumatologyCross-Sectional StudiesFemaleHumansJapanMaleSurveys and QuestionnairesChildEducationJuvenile idiopathic arthritisPracticeRheumatic diseasesSystemic lupus erythematosusTeam of mid-career pediatric rheumatologists alliance

Identifiers

PMID41580803
PMCPMC12914918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.